Company name: Hankang (Yunnan) Biotech
Description: Provider of CBD extraction services. The company is engaged in processing and extracting CBD from hemp. It produces 1.5 metric-tons daily.
Industry: Healthcare | Group: Other Healthcare | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company, a subsidiary of Biosynthesis Pharma Group, was acquired by Isodiol (CNQ: ISOL) for $500,000 on April 17, 2018.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 0.50
Last known valuation date: 17-Apr-2018